Skip to main content
Klotho Neurosciences, Inc. logo

Klotho Neurosciences, Inc. — Investor Relations & Filings

Ticker · KLTO ISIN · US7580831094 US Manufacturing
Filings indexed 209 across all filing types
Latest filing 2026-05-26 Proxy Solicitation & In…
Country US United States of America
Listing US KLTO

About Klotho Neurosciences, Inc.

https://klothoneuro.com/

Klotho Neurosciences, Inc. is a biopharmaceutical company focused on the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders. The company develops treatments for conditions with high unmet medical needs, including amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. Its core approach involves pioneering gene and cell therapies that utilize DNA and RNA as therapeutics. A key area of its research is centered on genomic therapies targeting the alpha-Klotho gene, a known regulator of aging. The company's portfolio consists of proprietary cell and gene therapy programs designed to offer transformative outcomes for patients.

Recent filings

Filing Released Lang Actions
PROXY STATEMENT
Proxy Solicitation & Information Statement
2026-05-26 English
CURRENT REPORT
M&A Activity Classification · 92% confidence The document is a U.S. SEC Form 8-K “Current Report” under Item 1.01, describing the entry into a material Agreement and Plan of Merger between Greenland Mines Ltd and Neo North Star Resources, Inc. It is an announcement of a merger transaction rather than a standalone financial report or proxy solicitation. This clearly falls under the M&A Activity category for merger proposals or takeover bids. Therefore, it should be classified as TAR.
2026-05-21 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2026
2026-05-20 English
AMENDMENT NO. 1 TO FORM 8-K
Regulatory Filings Classification · 90% confidence The document is an SEC Form 8-K/A (an amended Current Report) filing under the Securities Exchange Act of 1934. It amends a prior Form 8-K regarding the acquisition of Greenland Mines, Inc., specifically addressing Item 9.01 (financial statements and exhibits) and confirming no financials are required. This is a compliance/regulatory submission rather than an earnings release, annual report, M&A announcement, or other substantive report. It falls into the general Regulatory Filings category (RNS).
2026-05-19 English
CURRENT REPORT
Regulatory Filings Classification · 89% confidence The provided document is a Form 8-K current report filed with the SEC, specifically furnishing an investor presentation (Exhibit 99.1) and a press release (Exhibit 99.2) under Item 7.01. It does not contain the substantive content of the investor presentation or detailed financial statements itself, but rather notifies and attaches these materials. Under the “menu vs. meal” rule, this is an SEC regulatory announcement rather than the report/presentation itself. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-14 English
8-K - Greenland Mines Ltd (0001907223) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report under the Securities Exchange Act of 1934. The key content is the appointment of a new director to the Board of Directors, including detailed biographical information about the appointee. The document is dated April 17, 2026, and includes the signature of the CEO. The main item reported is Item 5.02, which relates to the departure or appointment of directors or certain officers. There are no financial statements or earnings data, no audit information, no voting results, no merger or acquisition details, and no other report types mentioned. Therefore, this filing is best classified as Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length (5899 characters) supports it being a full report rather than a brief announcement or certification. Confidence is high due to the clear and specific content about board appointment.
2026-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.